Breaking News Instant updates and real-time market news.

ONCE

Spark Therapeutics

08:29
10/13/17
10/13
08:29
10/13/17
08:29

Spark Therapeutics price target raised to $105 from $94 at Cantor Fitzgerald

Cantor Fitzgerald analyst Elemer Piros raised his price target for Spark Therapeutics to $105 following the unanimous advisory committee recommendation to approve Luxturna for the treatment of biallelic RPE65 mutation-associated retinal dystrophy. The analyst expects expedited approval for Luxturna well before its January 12, 2018, FDA action date. He keeps an Overweight rating on Spark Therapeutics.

  • 23

    Oct

  • 06

    Nov

  • 12

    Jan

ONCE Spark Therapeutics

10/13/17
STFL
10/13/17
NO CHANGE
Target $101
STFL
Buy
Spark Therapeutics price target raised to $101 from $92 at Stifel
Stifel analyst Stephen Willey said the vote of an FDA advisory committee in favor of the overall benefit-risk profile of Spark Therapeutics' voretigene neparvovec was "precisely in-line" with both his and the consensus expectation and he now expects the pricing/reimbursement debate to accelerate ahead of the January PDUFA date for the treatment. The analyst, who has adjusted both his expectations for pricing and some patient-related factors, raised his price target on Spark shares to $101 from $92 and keeps a Buy rating on the stock.
10/13/17
BMOC
10/13/17
NO CHANGE
BMOC
Spark Therapeutics price target raised to $101 from $89 at BMO Capital
BMO Capital analyst Matthew Luchini raised his price target on Spark after an FDA panel unanimously recommended approval of its LUXTURNA, a gene therapy for the treatment of patients with vision loss due to retinal disease. The analyst now "assigns full credit" to the drug in his estimates, but he adds that the company's hemophilia A drugs are the "primary" catalyst for the stock over the near-term. The analyst keeps an Outperform rating on the shares.
10/13/17
JEFF
10/13/17
NO CHANGE
Target $95
JEFF
Buy
Spark shares will continue to rise into 2018, says Jefferies
After hosting a "fireside chat" with the company and an FDA panel's unanimous vote in favor of Luxturna approval, Jefferies analyst Michael Yee says he believes shares of Spark Therapeutics will continue to go up into 2018. The analyst expects a "fairly modest but steady" uptake of Luxturna upon approval given a rare disease and limited centers to start. He believes his 2018 U.S. sales range of $40M-$50M is "theoretically doable." Yee keeps a Buy rating on Spark with a $95 price target.
10/12/17
RAJA
10/12/17
INITIATION
Target $96
RAJA
Outperform
Spark Therapeutics initiated with an Outperform at Raymond James
Raymond James analyst Reni Benjamin initiated Spark Therapeutics (ONCE) with an Outperform and $96 price target given expectations for LUXTURNA approval in 2018, encouraging clinical data seen with the hemophilia A program, a top partner in Pfizer (PFE) driving development in hemophilia B, and a platform technology to address large areas of unmet need.

TODAY'S FREE FLY STORIES

ETFC

E-Trade

$43.69

-0.23 (-0.52%)

16:07
10/19/17
10/19
16:07
10/19/17
16:07
Earnings
E-Trade reports Q3 EPS ex-items 55c, consensus 51c »

Reports Q3 revenue $599M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 21

    Oct

  • 07

    Nov

MXIM

Maxim Integrated

$50.09

0.24 (0.48%)

16:06
10/19/17
10/19
16:06
10/19/17
16:06
Earnings
Maxim Integrated sees Q2 adjusted EPS 61c-67c, consensus 57c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

TACO

Del Taco

$15.39

-0.01 (-0.06%)

16:06
10/19/17
10/19
16:06
10/19/17
16:06
Earnings
Del Taco reports Q3 EPS 13c, consensus 13c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

SPY

SPDR S&P 500 ETF Trust

$255.64

-0.08 (-0.03%)

, SPX

S&P 500

16:06
10/19/17
10/19
16:06
10/19/17
16:06
Periodicals
Trump said to lean toward Powell to head Federal Reserve, Politico says »

After President Donald…

SPY

SPDR S&P 500 ETF Trust

$255.64

-0.08 (-0.03%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXIM

Maxim Integrated

$50.09

0.24 (0.48%)

16:05
10/19/17
10/19
16:05
10/19/17
16:05
Hot Stocks
Breaking Hot Stocks news story on Maxim Integrated »

Maxim Integrated reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

HA

Hawaiian Holdings

$40.05

-0.1 (-0.25%)

16:05
10/19/17
10/19
16:05
10/19/17
16:05
Hot Stocks
Hawaiian Holdings sees FY17 ASMs up 3%-4% »

Sees FY17 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

MXIM

Maxim Integrated

$50.12

0.26 (0.52%)

16:05
10/19/17
10/19
16:05
10/19/17
16:05
Earnings
Maxim Integrated reports Q1 adjusted EPS 60c, consensus 56c »

Reports Q1 revenue $576M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CAI

CAI International

$31.31

-0.12 (-0.38%)

16:05
10/19/17
10/19
16:05
10/19/17
16:05
Earnings
CAI International reports Q3 EPS 90c, consensus 70c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

ATHN

athenahealth

$116.41

-4.37 (-3.62%)

16:04
10/19/17
10/19
16:04
10/19/17
16:04
Earnings
athenahealth reports Q3 EPS 56c, consensus 50c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

CVTI

Covenant Transportation

$27.76

1.16 (4.36%)

16:04
10/19/17
10/19
16:04
10/19/17
16:04
Hot Stocks
Covenant Transportation sees strong freight demand and tight trucking capacity »

Covenant CEO David Parker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HA

Hawaiian Holdings

$40.05

-0.1 (-0.25%)

16:04
10/19/17
10/19
16:04
10/19/17
16:04
Hot Stocks
Hawaiian Holdings sees Q4 operating revenue per ASM down 1% to up 2% »

Sees Q4 cost per ASM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

PBCT

People's United

16:03
10/19/17
10/19
16:03
10/19/17
16:03
Earnings
People's United reports Q3 EPS 26c, consensus 25c »

Net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

HA

Hawaiian Holdings

16:03
10/19/17
10/19
16:03
10/19/17
16:03
Earnings
Hawaiian Holdings reports Q3 adjusted EPS , consensus $1.85 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CVTI

Covenant Transportation

16:03
10/19/17
10/19
16:03
10/19/17
16:03
Earnings
Covenant Transportation reports Q3 EPS 25, consensus 17c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASRV

Ameriserve Financial

16:01
10/19/17
10/19
16:01
10/19/17
16:01
Hot Stocks
Ameriserve Financial Bank, USW announces new labor contract »

AmeriServ Financial Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGICA

Donegal Group

$16.49

0.04 (0.24%)

16:01
10/19/17
10/19
16:01
10/19/17
16:01
Hot Stocks
Donegal Group CEO takes medical leave of absence »

Donegal Mutual Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

UNP

Union Pacific

$111.94

1.56 (1.41%)

15:50
10/19/17
10/19
15:50
10/19/17
15:50
Options
Union Pacific calls see another day of extraordinary volume »

Union Pacific calls see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SRC

Spirit Realty

$8.08

-0.39 (-4.60%)

15:49
10/19/17
10/19
15:49
10/19/17
15:49
Hot Stocks
Spirit Realty weakness attributed to report of Sun Capital seeking Shopko buyer »

The weakness in shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

FTR

Frontier Communications

15:45
10/19/17
10/19
15:45
10/19/17
15:45
Options
Frontier Communications call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

CZFC

Citizens First

15:42
10/19/17
10/19
15:42
10/19/17
15:42
Hot Stocks
Citizens First raises semiannual dividend 25% to 10c per share »

On October 19, the Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$24.15

-0.955 (-3.80%)

15:34
10/19/17
10/19
15:34
10/19/17
15:34
Options
Skechers options imply 14.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

BCS

Barclays

$10.16

0.01 (0.10%)

15:31
10/19/17
10/19
15:31
10/19/17
15:31
Periodicals
Barclays being sued for $850M for copper market abuse, Bloomberg reports »

Red Kite Management is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

GE

General Electric

$23.72

0.595 (2.57%)

15:30
10/19/17
10/19
15:30
10/19/17
15:30
Options
100K GE Oct 27th 21.5 puts trade ahead of earnings »

100K GE Oct 27th 21.5…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

GE

General Electric

$23.72

0.595 (2.57%)

15:29
10/19/17
10/19
15:29
10/19/17
15:29
Technical Analysis
Technical Earnings Preview: General Electric in well-defined downtrend »

Shares have been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

WFBI

WashingtonFirst

$36.23

-0.25 (-0.69%)

15:28
10/19/17
10/19
15:28
10/19/17
15:28
Earnings
WashingtonFirst reports Q3 core EPS 43c, consensus 41c »

WashingtonFirst President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.